Literature DB >> 25101884

CFTR potentiators: not an open and shut case.

John P Clancy1.   

Abstract

Insights into the positive and negative effects of drugs to treat cystic fibrosis (CF) patients with a common mutation raise questions about how we discover and translate CF therapeutics (Veit et al. and Cholon et al., this issue).
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25101884     DOI: 10.1126/scitranslmed.3009674

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  1 in total

1.  Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Sadis Matalon; Zsuzsanna Bebok
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.